Image 1
Cryselle Kit
Product Images NDC 0555-9049
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cryselle (NDC 0555-9049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Image 4
This is a chart displaying the effectiveness of various birth control methods in preventing pregnancies. The text describes the number of pregnancies per 100 women in one year that can be expected with each method, with the most effective being sterilization, intrauterine devices, and implants. The text also mentions birth control pills and injections. It notes that avoiding sex during the most fertile days is not an effective method of birth control, and that not using any birth control at all is the least effective method.*
Image 5
Image 6
Image 7
Image 8
This is a pack of oral contraceptive pills with 6 blister card dispensers, each containing 28 tablets. The usual dosage is one white tablet daily for 21 consecutive days followed by one light-green inert tablet daily for 7 consecutive days. It is important to store the medication in controlled room temperature and protect from light and humid conditions. The enclosed package insert should be read for full prescribing information. The manufacturer of these tablets is Teva Pharmaceuticals USA, INC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
